Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
Source: Critical Care - Category: Intensive Care Authors: Paulo Roberto Barbosa Evora Tags: Letter Source Type: research
More News: Intensive Care